These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 51872)
21. Effect of inhibitors of prostaglandin synthesis and prostaglandins E2 and F2alpha on the immunologic release of mediators of inflammation from actively sensitized guinea-pig lung. Hitchcock M J Pharmacol Exp Ther; 1978 Nov; 207(2):630-40. PubMed ID: 712645 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of histamine and SRS-A from monkey lung tissue by chlorophenesin. Malley A; Baecher L J Immunol; 1971 Aug; 107(2):586-8. PubMed ID: 4105542 [No Abstract] [Full Text] [Related]
23. Symposium on allergic lung disease. IV. Immunologic mechanisms for release of chemical mediators of anaphylaxis from human lung tissue. Kaliner M Can Med Assoc J; 1974 Feb; 110(4):431 passim. PubMed ID: 4134081 [TBL] [Abstract][Full Text] [Related]
24. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. Liu MC; Proud D; Lichtenstein LM; MacGlashan DW; Schleimer RP; Adkinson NF; Kagey-Sobotka A; Schulman ES; Plaut M J Immunol; 1986 Apr; 136(7):2588-95. PubMed ID: 2419444 [TBL] [Abstract][Full Text] [Related]
25. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP. Orange RP; Kaliner MA; Laraia PJ; Austen KF Fed Proc; 1971; 30(6):1725-9. PubMed ID: 4108129 [No Abstract] [Full Text] [Related]
26. Separation of slow reacting substance of anaphylaxis (SRS-A) from human lung into four biologically active fractions. Takahashi H; Webster ME; Newball HH J Immunol; 1976 Sep; 117(3):1039-44. PubMed ID: 8568 [TBL] [Abstract][Full Text] [Related]
27. IgE immune complexes induce immediate and prolonged release of leukotriene C4 (LTC4) from rat alveolar macrophages. Rankin JA; Hitchcock M; Merrill WW; Huang SS; Brashler JR; Bach MK; Askenase PW J Immunol; 1984 Apr; 132(4):1993-9. PubMed ID: 6421931 [TBL] [Abstract][Full Text] [Related]
28. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. Kay AB; Austen KF J Immunol; 1971 Sep; 107(3):899-902. PubMed ID: 4105937 [No Abstract] [Full Text] [Related]
29. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions. Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109 [TBL] [Abstract][Full Text] [Related]
30. Inhibition by antihistamines of the immunologic release of slow reacting substance of anaphylaxis (SRS-A) in the rat. Koopman WJ; Orange RP; Austen KF Trans Assoc Am Physicians; 1970; 83():225-34. PubMed ID: 4101143 [No Abstract] [Full Text] [Related]
31. Slow reacting substance as a preformed mediator from human lung. Turnbull LS; Jones DG; Kay AB Immunology; 1976 Nov; 31(5):813-20. PubMed ID: 11180 [TBL] [Abstract][Full Text] [Related]
32. Formation of slow-reacting substance of anaphylaxis in human lung tissue and cells before release. Lewis RA; Wasserman SI; Goetzi EJ; Austen KF J Exp Med; 1974 Nov; 140(5):1133-46. PubMed ID: 4378429 [TBL] [Abstract][Full Text] [Related]
33. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. Undem BJ; Peachell PT; Lichtenstein LM J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368 [TBL] [Abstract][Full Text] [Related]
34. Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro. Shelhamer JH; Marom Z; Kaliner M J Clin Invest; 1980 Dec; 66(6):1400-8. PubMed ID: 7440722 [TBL] [Abstract][Full Text] [Related]
35. Selective inhibition by betamethasone of allergen-induced release of SRS-A from human lung. Hammond CV; Hammond MD; Taylor WA Int Arch Allergy Appl Immunol; 1982; 67(3):284-6. PubMed ID: 6174455 [TBL] [Abstract][Full Text] [Related]
36. Inhibitory action of verapamil and chlorpromazine on the release of slow-reacting substance of anaphylaxis from cat lung. Dell'Osa D; Temple DM Pharmacol Res Commun; 1986 Nov; 18(11):1043-52. PubMed ID: 2432620 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological studies on the release of slow reacting substance of anaphylaxis during anti-immunoglobulin E antibody mediated passive peritoneal anaphylaxis in rats. Nagai H; Yamada H; Matsuura N; Iwamoto T; Choi SH; Koda A J Pharmacobiodyn; 1987 Jan; 10(1):49-54. PubMed ID: 3108486 [TBL] [Abstract][Full Text] [Related]
38. Immunological release of histamine and slow-reacting substance in domestic fowl. Chand N; Eyre P Can J Comp Med; 1978 Oct; 42(4):519-24. PubMed ID: 84701 [TBL] [Abstract][Full Text] [Related]
39. [Release of histamine and slow reacting substance of anaphylaxis (SRS-A) from sensitized guinea-pig lungs. 2. Effects of bronchodilators and cyclic nucleotides]. Kitamura S; Ishihara Y; Sasaki K Nihon Kyobu Shikkan Gakkai Zasshi; 1976 Nov; 14(11):650-5. PubMed ID: 64635 [No Abstract] [Full Text] [Related]
40. Inhibition profiles of picumast and ketotifen on the in vitro release of prostanoids, slow-reacting substance of anaphylaxis, histamine and enzyme from human leukocytes and rat alveolar macrophages. Wilhelms OH Int Arch Allergy Appl Immunol; 1987; 82(3-4):547-9. PubMed ID: 2437054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]